Pharma

Alivexis and Melodia Therapeutics Join Forces to Develop MDI-0151 for Inflammatory Diseases

Alivexis and Melodia Therapeutics Join Forces to Develop MDI-0151 for Inflammatory Diseases

Shots: Alivexis has signed an exclusive license agreement with Melodia Therapeutic...

Biophytis and Blanver Collaborate to Develop BIO101 for Treating Multiple Indications

Biophytis and Blanver Collaborate to Develop BIO101 for Treating Multiple Indications

Shots: Biophytis and Blanver have entered into an exclusive license agreement to d...

Belharra Therapeutics Partners with Sanofi to Discover New Small Molecules Addressing Immunological Diseases

Belharra Therapeutics Partners with Sanofi to Discover New Small Molecules Addressing Immunological Diseases

Shots: Belharra & Sanofi have partnered to discover new small molecules for im...

Ascidian Therapeutics Join Hands with Roche to Discover and Develop RNA Exon Editing Therapies for Neurological Diseases

Ascidian Therapeutics Join Hands with Roche to Discover and Develop RNA Exon Editing Therapies for Neurological Diseases

Shots: Ascidian Therapeutics and Roche have signed a research collaboration and li...

Takeda Enters into an Option Agreement with Ascentage Pharma for Olverembatinib to Treat Chronic Myeloid Leukemia

Takeda Enters into an Option Agreement with Ascentage Pharma for Olverembatinib to Treat Chronic Myeloid Leukemia

Shots: Takeda has entered into an option to license agreement with Ascentage to ob...

AbbVie Teams Up FutureGen to Advance Next-Generation Therapy to Address Inflammatory Bowel Disease

AbbVie Teams Up FutureGen to Advance Next-Generation Therapy to Address Inflammatory Bowel Disease

Shots: AbbVie & FutureGen Biopharmaceutical have entered into a license agreem...

Image